Pharmaceutical Industry Trends & News - Pharmaceutical Technology

PremiumFeatures

The shrinking return on investment for Nordic innovation

Nordic biopharma innovation outpaces commercialisation as regional biotechs struggle to raise the capital needed to upscale.

Frankie Fattorini

News

Novo taps Anthropic’s Claude to ‘supercharge’ R&D efforts

Robert Barrie

News

Sling ropes in $123m for oral thyroid eye disease drug

Robert Barrie

News

Cellares and GenomeFrontier to assess automated GF-CART01 production

News

Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy

News

Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials

News

Eli Lilly and QurCan sign genetic medicine deal

News

Gilead and PAHO agree to expedite lenacapavir access for HIV prevention

Analysis

PremiumAnalyst Comment

Looking beyond short-term turmoil, Syngene is investing for the future

Dominic Tyer

PremiumAnalyst Comment

ERS 2026: obesity, an independent obstruction to biologic-treated asthma

GlobalData Healthcare

PremiumAnalyst Comment

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

GlobalData Healthcare

PremiumFeatures

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Annabel Kartal Allen

Themes

Partner Content

Industry partnership will determine the success of the transition to low-GWP pMDIs

With regulatory conditions tightening around climate impact and environmental persistence of medical propellants, HFA-152a is a practical route to maintain clinical performance, patient outcomes and supply continuity of inhalers. However,...

More themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Hodgkin Lymphoma: Epidemiology Report and Forecast

$9995.00

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

$9995.00

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

$17995.00

Membranous Glomerulonephritis - Global Clinical Trials Review, 2026

$3450.00

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

$3450.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Novo taps Anthropic’s Claude to ‘supercharge’ R&D efforts

Sling ropes in $123m for oral thyroid eye disease drug

Cellares and GenomeFrontier to assess automated GF-CART01 production

Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy

Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials

Eli Lilly and QurCan sign genetic medicine deal

Gilead and PAHO agree to expedite lenacapavir access for HIV prevention

Looking beyond short-term turmoil, Syngene is investing for the future

ERS 2026: obesity, an independent obstruction to biologic-treated asthma

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

Staunch biotech competition spurs new secretive tactics, shifts investor approach

Industry partnership will determine the success of the transition to low-GWP pMDIs

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Membranous Glomerulonephritis - Global Clinical Trials Review, 2026

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Hodgkin Lymphoma: Epidemiology Report and Forecast

Glioblastoma (GBM): Epidemiology Report and Forecast, 2026

Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035

Membranous Glomerulonephritis - Global Clinical Trials Review, 2026

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing